Definitive Contract 75F40123C00193
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a $148,940 firm-fixed-price purchase order contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, to conduct research on elucidating antimicrobial resistance pharmacogenetic relationships for organisms and drug/drug classes of critical/serious concern. This work is intended to advance regulatory science and public health. The contract, which has a completion date of June 30,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,311 firm fixed-price delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on July 22, 2019. This task order, designated Task A06, requires JMI Laboratories to determine the in vitro minimum inhibitory concentration (MIC) of a candidate antimicrobial product against a panel of Listeria monocytogenes clinical isolates. The work will be performed in North Liberty, Iowa, with...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $195.7K delivery order to Element Materials Technology Iowa City Inc., operating as JMI Laboratories, for in vitro screening of antibacterial activity against public health disease pathogens. The contract, which was awarded on April 21, 2022, with an ultimate completion date of May 1, 2023, is structured as a firm fixed-price delivery order under the In Vitro Assessments of Antimicrobial Activity (IVAAA)...
- Element Materials Technology Iowa City Inc., operating as JMI Laboratories, was awarded a delivery order valued at $193,325 by the National Institute of Allergy and Infectious Diseases (NIAID) on August 31, 2023. The contract, which will be completed by August 30, 2024, requires the contractor to determine the in vitro minimal inhibitory concentration (MIC) of candidate products against a panel of Neisseria gonorrhoeae isolates. This delivery order was issued under the In Vitro Assessments of...
- The Department of Health and Human Services Food and Drug Administration awarded a $33,000 firm fixed price purchase order to Bhayana Brothers LLC. The contract is to provide microbiology laboratory services in support of the FDA New York Laboratory's medical product regulatory analysis program. Specifically, the prime contractor will service the microbiology laboratory section located in Jamaica, New York, including operating bio clean room suit capabilities. The contract has a period of...
- The U.S. Food and Drug Administration (FDA) awarded a $162,354.10 firm-fixed-price purchase order contract to Molecular Epidemiology Inc., a woman-owned, for-profit business, for the National Antimicrobial Resistance Monitoring System (NARMS) Retail Meat Sample Collection and Testing program. The contract, which has a completion date of July 24, 2023, requires Molecular Epidemiology Inc. to provide critical testing, analysis, and research services to support the FDA's food safety and public...
- This federal contract award, valued at $338,101.30, was issued by the Food and Drug Administration (FDA) to Molecular Epidemiology Inc., a woman-owned small business. The contract is for the continuation of agricultural water testing and analysis services, without any set-aside designation. Molecular Epidemiology Inc. is an experienced provider of advanced scientific testing and analysis services for federal agencies, with a focus on food safety, public health, and microbiological research....
- This federal contract award is for the delivery of supplies to support the Centers for Disease Control and Prevention's (CDC) National Antimicrobial Resistance Monitoring System (NARMS) program. The prime contractor is Remel Inc., doing business as Thermo Fisher Scientific Remel Products, a manufacturer of microbiology laboratory products and diagnostic test kits. The contract, valued at $144,305.14, is a firm fixed-price delivery order awarded by the Department of Health and Human Services'...
- This federal contract award is a delivery order under the In Vitro Antimicrobial Assessments 2011-2018 indefinite delivery/indefinite quantity (IDIQ) contract vehicle, issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The $90,327.00 firm-fixed-price task order is for conducting microbiological inhibitory concentration (MIC) testing of bovine lactoferrin against five bacterial vaginosis pathogens. The...
- This federal contract award is for a semi-automated microbroth dilution assay system for the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) Molecular Characterization of Foodborne Pathogens Research (MCFPR) program. The $67,318.08 fixed-price contract was awarded to Remel Inc., a subsidiary of Thermo Fisher Scientific, without any set-aside designation. The contract was issued through a full and open solicitation, and the award was based on the lowest priced...
This federal contract award is for antimicrobial resistance laboratory services with the Food and Drug Administration (FDA). The $1,122,383.45 definitive contract, with a firm fixed price, was awarded to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, a for-profit Subchapter S Corporation. The contract is an option exercise and contract officer representative change to an existing contract. JMI Laboratories is a microbiology specialist company that provides a range of antimicrobial resistance testing and research services to federal agencies, including the Department of Health and Human Services. The work under this contract will involve conducting an interlaboratory study to assess biological variability in minimum inhibitory concentration measurements using the broth microdilution method. This contract was not set aside for small businesses.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Assessing Biological Variability in Minimum Inhibitory Concentrations Measured by the Broth Microdilution Method | FDA-23-SOW-1266015 | Department of Health and Human Services Food and Drug Administration | Solicitation 1/1 | 7/10/23, 3:16 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $228.0k | 9/24/25 | |
| P00003 | Other Administrative Action | $0 | 7/1/25 | |
| P00002 | Other Administrative Action | $0 | 11/3/24 | |
| P00001 | Other Administrative Action | $249.9k | 8/21/24 | |
| Not listed | Not listed | $199.2k | 9/14/23 |